Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.20p
   
  • Change Today:
      0.050p
  • 52 Week High: 13.55p
  • 52 Week Low: 2.40p
  • Currency: UK Pounds
  • Shares Issued: 697.20m
  • Volume: 1,921,228
  • Market Cap: £22.31m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
48.77% below the market average48.77% below the market average48.77% below the market average48.77% below the market average48.77% below the market average
17.95% above the sector average17.95% above the sector average17.95% above the sector average17.95% above the sector average17.95% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
78.45% below the market average78.45% below the market average78.45% below the market average78.45% below the market average78.45% below the market average
69.57% below the sector average69.57% below the sector average69.57% below the sector average69.57% below the sector average69.57% below the sector average
Price Chg 3m
31.39% above the market average31.39% above the market average31.39% above the market average31.39% above the market average31.39% above the market average
30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
29.07% below the market average29.07% below the market average29.07% below the market average29.07% below the market average29.07% below the market average
9.52% below the sector average9.52% below the sector average9.52% below the sector average9.52% below the sector average9.52% below the sector average
Momentum 20
38.78% below the market average38.78% below the market average38.78% below the market average38.78% below the market average38.78% below the market average
28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE
68.6% below the market average68.6% below the market average68.6% below the market average68.6% below the market average68.6% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
59.04% below the market average59.04% below the market average59.04% below the market average59.04% below the market average59.04% below the market average
30.43% below the sector average30.43% below the sector average30.43% below the sector average30.43% below the sector average30.43% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
79.14% below the market average79.14% below the market average79.14% below the market average79.14% below the market average79.14% below the market average
39.13% below the sector average39.13% below the sector average39.13% below the sector average39.13% below the sector average39.13% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
35% below the market average35% below the market average35% below the market average35% below the market average35% below the market average
2.33% below the sector average2.33% below the sector average2.33% below the sector average2.33% below the sector average2.33% below the sector average
Cash
64.19% below the market average64.19% below the market average64.19% below the market average64.19% below the market average64.19% below the market average
64.44% below the sector average64.44% below the sector average64.44% below the sector average64.44% below the sector average64.44% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
6.11% above the market average6.11% above the market average6.11% above the market average6.11% above the market average6.11% above the market average
6.25% above the sector average6.25% above the sector average6.25% above the sector average6.25% above the sector average6.25% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 3.20p
Change Today 0.050p
% Change 1.59 %
52 Week High 13.55p
52 Week Low 2.40p
Volume 1,921,228
Shares Issued 697.20m
Market Cap £22.31m

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.6% below the market average53.6% below the market average53.6% below the market average53.6% below the market average53.6% below the market average
13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average
Price Trend
87.64% below the market average87.64% below the market average87.64% below the market average87.64% below the market average87.64% below the market average
73.91% below the sector average73.91% below the sector average73.91% below the sector average73.91% below the sector average73.91% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 11-Jul-2025

Time Volume / Share Price
17:05 750,000 @ 3.20p
16:36 29,000 @ 3.18p
16:35 32,000 @ 3.20p
16:35 32,000 @ 3.20p
16:23 24 @ 3.20p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page